Preview

Эпидемиология и Вакцинопрофилактика

Расширенный поиск

Таргетное секвенирование в диагностике инфекционных заболеваний: современное состояние и перспективы

https://doi.org/10.31631/2073-3046-2026-25-1-111-120

Аннотация

Актуальность. Таргетное секвенирование постепенно занимает все более важное место в диагностике инфекционных заболеваний на фоне ряда ограничений традиционных методов и высокой стоимости/сложности метагеномного секвенирования. Цель. Обобщить современные подходы к таргетному NGS в диагностике инфекций, показать его преимущества и ограничения, по сравнению с культуральными и ПЦР-методами, а также с метагеномным секвенированием, и обсудить перспективы внедрения в рутинную практику и систему геномного эпиднадзора. Заключение. Показано, что таргетное секвенирование, при сопоставимых с традиционными методами сроках и стоимости, позволяет существенно повышать чувствительность и специфичность выявления возбудителей, точно типировать патогены и одновременно получать данные, пригодные для эпиднадзора и мониторинга устойчивости к противомикробным препаратам. Обсуждаются ключевые технологические и организационные барьеры, а также направления развития панелей и биоинформатических решений, которые способны сделать таргетное NGS одним из базовых инструментов инфекционной диагностики в ближайшие годы.

Об авторах

М. И. Надтока
ФБУН Центральный НИИ Эпидемиологии Роспотребнадзора
Россия

Максим Игоревич Надтока – научный сотрудник

+7 (916)080-97-50

Москва



Г. В. Роев
ФБУН Центральный НИИ Эпидемиологии Роспотребнадзора; ФГАОУ ВО «Московский физико-технический институт (национальный исследовательский университет)»
Россия

Герман Викторович Роев – биоинформатик; аспирант

+7 (925) 440-35-50

Москва



К. Ф. Хафизов
ФБУН Центральный НИИ Эпидемиологии Роспотребнадзора
Россия

Камиль Фаридович Хафизов – заведующий лабораторией

+7 (917) 597-20-85

Москва



В. Г. Акимкин
ФБУН Центральный НИИ Эпидемиологии Роспотребнадзора
Россия

Василий Геннадьевич Акимкин – директор

Москва



Список литературы

1. Li Z.-J., Zhang H.-Y., Ren L.-L., et al. Etiological and epidemiological features of acute respiratory infections in China . Nat Commun. 2021. Т. 12, № 1. С. 5026.

2. Bender R. G., Sirota S. B., Swetschinski L. R., et al. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021 . The Lancet Infectious Diseases. 2024. Т. 24, № 9. С. 974–1002.

3. Mahony J. B. Detection of Respiratory Viruses by Molecular Methods . Clin Microbiol Rev. 2008. Т. 21, № 4. С. 716–747.

4. Rousogianni E., Perlepe G., Boutlas S., et al. Clinical features and outcomes of viral respiratory infections in adults during the 2023–2024 winter season . Sci Rep. 2025. Т. 15, № 1. С. 35800.

5. Ginocchio C. C., McAdam A. J. Current Best Practices for Respiratory Virus Testing . J Clin Microbiol. 2011. Т. 49, № 9_Supplement.

6. Wang X., Li Y., Deloria-Knoll M., et al. Global burden of acute lower respiratory infection associated with human parainfluenza virus in children younger than 5 years for 2018: a systematic review and meta-analysis . The Lancet Global Health. 2021. Т. 9, № 8. С. e1077–e1087.

7. Wang X., Li Y., Deloria-Knoll M., et al. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study . The Lancet Global Health. 2021. Т. 9, № 1. С. e33–e43.

8. Babawale P. I., Guerrero-Plata A. Respiratory Viral Coinfections: Insights into Epidemiology, Immune Response, Pathology, and Clinical Outcomes . Pathogens. 2024. Т. 13, № 4. С. 316.

9. Yang S., Rothman R. E. PCR-based diagnostics for infectious diseases: uses, limitations, and future applications in acute-care settings . The Lancet Infectious Diseases. 2004. Т. 4, № 6. С. 337–348.

10. Amat J. A. R., Dudgeon S. N., Cheemarla N. R., et al. Nasal biomarker testing to rule out viral respiratory infection and triage samples: a test performance study . eBioMedicine. 2025. Т. 117. С. 105820.

11. Mamanova L., Coffey A. J., Scott C. E., et al. Target-enrichment strategies for next-generation sequencing . Nat Methods. 2010. Т. 7, № 2. С. 111–118.

12. Nafea A. M., Wang Y., Wang D., et al. Application of next-generation sequencing to identify different pathogens . Front. Microbiol. 2024. Т. 14. С. 1329330.

13. Houldcroft C. J., Beale M. A., Breuer J. Clinical and biological insights from viral genome sequencing . Nat Rev Microbiol. 2017. Т. 15, № 3. С. 183–192.

14. Li N., Cai Q., Miao Q., et al. High‐Throughput Metagenomics for Identification of Pathogens in the Clinical Settings . Small Methods. 2021. Т. 5, № 1. С. 2000792.

15. Yin Y., Zhu P., Guo Y., et al. Enhancing lower respiratory tract infection diagnosis: implementation and clinical assessment of multiplex PCR-based and hybrid capture-based targeted next-generation sequencing . eBioMedicine. 2024. Т. 107. С. 105307.

16. Gauthier N. P. G., Chorlton S. D., Krajden M., et al. Agnostic Sequencing for Detection of Viral Pathogens . Clin Microbiol Rev. 2023. Т. 36, № 1. С. e00119–22.

17. He Y., Fang K., Shi X., et al. Enhanced DNA and RNA pathogen detection via metagenomic sequencing in patients with pneumonia . J Transl Med. 2022. Т. 20, № 1. С. 195.

18. Tan J. K., Servellita V., Stryke D., et al. Laboratory validation of a clinical metagenomic next-generation sequencing assay for respiratory virus detection and discovery . Nat Commun. 2024. Т. 15, № 1. С. 9016.

19. Li Y., Deng X., Hu F., et al. Metagenomic analysis identified co-infection with human rhinovirus C and bocavirus 1 in an adult suffering from severe pneumonia . Journal of Infection. 2018. Т. 76, № 3. С. 311–313.

20. Marra P. S., Marra A. R., Chen E., et al. Metagenomic Next-generation Sequencing in Patients With Infectious Meningoencephalitis: A Comprehensive Systematic Literature Review and Meta-analysis . Open Forum Infectious Diseases. 2025. Т. 12, № 5. С. ofaf274.

21. Wahl A., Huptas C., Neuhaus K. Comparison of rRNA depletion methods for efficient bacterial mRNA sequencing . Sci Rep. 2022. Т. 12, № 1. С. 5765.

22. Kim M., Parrish R. C., Tisza M. J., et al. Host DNA depletion on frozen human respiratory samples enables successful metagenomic sequencing for microbiome studies. Commun Biol. 2024. Т. 7, № 1. С. 1590.

23. Takemae N., Kuba Y., Oba K., et al. Direct genome sequencing of respiratory viruses from low viral load clinical specimens using the target capture sequencing technology. Microbiol Spectr / под ред. Liu B. M. 2024. Т. 12, № 11. С. e00986–24.

24. Zhang P., Liu B., Zhang S., et al. Clinical application of targeted next-generation sequencing in severe pneumonia: a retrospective review. Crit Care. 2024. Т. 28, № 1. С. 225.

25. Chen Q., Yi J., Liu Y., et al. Clinical diagnostic value of targeted next‑generation sequencing for infectious diseases (Review). Mol Med Rep. 2024. Т. 30, № 3. С. 153.

26. Ding Y., Jing C., Wei J., et al. Comparison of the diagnostic capabilities of tNGS and mNGS for pathogens causing lower respiratory tract infections: a prospective observational study. Front. Cell. Infect. Microbiol. 2025. Т. 15. С. 1578939.

27. Zhou B., Deng Y.-M., Barnes J. R., et al. Multiplex Reverse Transcription-PCR for Simultaneous Surveillance of Influenza A and B Viruses. J Clin Microbiol / под ред. McAdam A. J. 2017. Т. 55, № 12. С. 3492–3501.

28. Huang C., Huang Y., Wang Z., et al. Multiplex PCR-based next generation sequencing as a novel, targeted and accurate molecular approach for periprosthetic joint infection diagnosis. Front. Microbiol. 2023. Т. 14. С. 1181348.

29. Yang K., Zhao J., Wang T., et al. Clinical application of targeted next-generation sequencing in pneumonia diagnosis among cancer patients. Front. Cell. Infect. Microbiol. 2025. Т. 15. С. 1497198.

30. Sun W., Zheng L., Kang L., et al. Comparative analysis of metagenomic and targeted next-generation sequencing for pathogens diagnosis in bronchoalveolar lavage fluid specimens. Front. Cell. Infect. Microbiol. 2024. Т. 14. С. 1451440.

31. Yang J., Wang Y., Yang L., et al. Laboratory validation of targeted next-generation sequencing assay for pathogen detection in lower respiratory infection. Microbiol Spectr / под ред. Georghiou S. B. 2025. Т. 13, № 7. С. e01751–24.

32. Liu T., Chen Z., Chen W., et al. A benchmarking study of SARS-CoV-2 whole-genome sequencing protocols using COVID-19 patient samples. iScience. 2021. Т. 24, № 8. С. 102892.

33. Xie N. G., Wang M. X., Song P., et al. Designing highly multiplex PCR primer sets with Simulated Annealing Design using Dimer Likelihood Estimation (SADDLE). Nat Commun. 2022. Т. 13, № 1. С. 1881.

34. Gao L., Li L., Fang B., et al. Carryover Contamination-Controlled Amplicon Sequencing Workflow for Accurate Qualitative and Quantitative Detection of Pathogens: a Case Study on SARS-CoV-2. Microbiol Spectr / под ред. Kibenge F. S. B. 2023. Т. 11, № 3. С. e00206–23.

35. Chen W., Chen H., Liu Z., et al. A case report of confirmed difficult pulmonary tuberculosis based on the hybrid capture-based tNGS method. BMC Pulm Med. 2025. Т. 25, № 1. С. 64.

36. Charre C., Ginevra C., Sabatier M., et al. Evaluation of NGS-based approaches for SARS-CoV-2 whole genome characterisation. Virus Evolution. 2020. Т. 6, № 2. С. veaa075.

37. Itokawa K., Sekizuka T., Hashino M., et al. Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR. PLoS ONE / под ред. Kalendar R. 2020. Т. 15, № 9. С. e0239403.

38. Daviña-Núñez C., Pérez S., Cabrera-Alvargonzález J. J., et al. Performance of amplicon and capture based next-generation sequencing approaches for the epidemiological surveillance of Omicron SARS-CoV-2 and other variants of concern. PLoS ONE / под ред. Tsang H. F. 2024. Т. 19, № 4. С. e0289188.

39. Rehn A., Braun P., Knüpfer M., et al. Catching SARS-CoV-2 by Sequence Hybridization: a Comparative Analysis. mSystems / под ред. Mackelprang R. 2021. Т. 6, № 4. С. 10.1128/msystems.00392-21.

40. Barra G. B., Santa Rita T. H., Mesquita P. G., et al. Analytical Sensitivity and Specificity of Two RT-qPCR Protocols for SARS-CoV-2 Detection Performed in an Automated Workflow. Genes. 2020. Т. 11, № 10. С. 1183.

41. Kuang Y., Tan W., Hu C., et al. Diagnosis value of targeted and metagenomic sequencing in respiratory tract infection. Front. Cell. Infect. Microbiol. 2024. Т. 14. С. 1498512.

42. Kwambana-Adams B. Global burden of meningitis and implications for strategy. The Lancet Neurology. 2023. Т. 22, № 8. С. 646–648.

43. Bloch K. C., Glaser C. A. Encephalitis Surveillance through the Emerging Infections Program, 1997–2010. Emerg. Infect. Dis. 2015. Т. 21, № 9.

44. Sulaiman T., Salazar L., Hasbun R. Acute versus subacute community-acquired meningitis: Analysis of 611 patients. Medicine. 2017. Т. 96, № 36. С. e7984.

45. Li J., Zhang L., Yang X., et al. Diagnostic Significance of Targeted Next-Generation Sequencing in Central Nervous System Infections in Neurosurgery of Pediatrics. IDR. 2023. Т. Volume 16. С. 2227–2236.

46. Tram T. T. B., Trieu L. P. T., Nhat L. T. H., et al. Targeted sequencing from cerebrospinal fluid for rapid identification of drug-resistant tuberculous meningitis. J Clin Microbiol / под ред. Turenne C. Y. 2024. Т. 62, № 4. С. e01287–23.

47. Bolger A. M., Lohse M., Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014. Т. 30, № 15. С. 2114–2120.

48. Langmead B., Salzberg S. L. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012. Т. 9, № 4. С. 357–359.

49. Bushnell B., Rood J., Singer E. BBMerge – Accurate paired shotgun read merging via overlap. PLoS ONE / под ред. Biggs P. J. 2017. Т. 12, № 10. С. e0185056.

50. Fu L., Niu B., Zhu Z., et al. CD-HIT: accelerated for clustering the next-generation sequencing data. Bioinformatics. 2012. Т. 28, № 23. С. 3150–3152.

51. Wood D. E., Lu J., Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019. Т. 20, № 1. С. 257.

52. Buchfink B., Xie C., Huson D. H. Fast and sensitive protein alignment using DIAMOND. Nat Methods. 2015. Т. 12, № 1. С. 59–60.

53. Shen Z., Qu W., Wang W., et al. MPprimer: a program for reliable multiplex PCR primer design. BMC Bioinformatics. 2010. Т. 11, № 1. С. 143.

54. Ye J., Coulouris G., Zaretskaya I., et al. Primer-BLAST: A tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012. Т. 13, № 1. С. 134.

55. Lu J., Johnston A., Berichon P., et al. PrimerSuite: A High-Throughput Web-Based Primer Design Program for Multiplex Bisulfite PCR. Sci Rep. 2017. Т. 7, № 1. С. 41328.

56. Kechin A., Borobova V., Boyarskikh U., et al. NGS-PrimerPlex: High-throughput primer design for multiplex polymerase chain reactions. PLoS Comput Biol / под ред. Pertea M. 2020. Т. 16, № 12. С. e1008468.

57. Yang F., Jiang L., Cao Q., et al. Evaluation of targeted next-generation sequencing for microbiological diagnosis of acute lower respiratory infection. Front. Microbiol. 2025. Т. 16. С. 1615965.

58. Chen W., Liu G., Cui L., et al. Evaluation of metagenomic and pathogen-targeted next-generation sequencing for diagnosis of meningitis and encephalitis in adults: A multicenter prospective observational cohort study in China. Journal of Infection. 2024. Т. 88, № 5. С. 106143.

59. Kambli P., Ajbani K., Andrews A. A., et al. Targeted Next Generation Sequencing (tNGS) for detection of drug-resistant tuberculous meningitis: Is this sequencing technology ready for prime time?. Indian Journal of Medical Microbiology. 2024. Т. 51. С. 100665.

60. Patil S., Wen F., Hanafiah A., et al. Editorial: Targeted next-generation sequencing for pathogen and antimicrobial resistance (AMR) identification and profiling. Front. Cell. Infect. Microbiol. 2025. Т. 15. С. 1633941.


Рецензия

Для цитирования:


Надтока М.И., Роев Г.В., Хафизов К.Ф., Акимкин В.Г. Таргетное секвенирование в диагностике инфекционных заболеваний: современное состояние и перспективы. Эпидемиология и Вакцинопрофилактика. 2026;25(1):111-120. https://doi.org/10.31631/2073-3046-2026-25-1-111-120

For citation:


Nadtoka M.I., Roev G.V., Khafizov K.F., Akimkin V.G. Targeted Sequencing in Infectious Disease Diagnostics: Current State and Future Prospects. Epidemiology and Vaccinal Prevention. 2026;25(1):111-120. (In Russ.) https://doi.org/10.31631/2073-3046-2026-25-1-111-120

Просмотров: 410

JATS XML


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)